Based on our new estimates, Invisio is trading at an EV/EBIT of 41x-28x for ’22e-’23e, which is a discount of 20% vs peer median, although we expect a higher sales and EBIT CAGR in 2021-23e. In terms of the Q4’21e outlook, we expect the global reopening will enable important physical sales meetings, which will likely have a positive effect on Invisio’s chances of winning important new orders.
Aktuellt
SENASTE
